Daniel L. Ruderman is director of digital pathology and oncology biomarker development at Genentech, where his work combines computational biology and data science to advance cancer diagnostics. Ruderman earned his undergraduate and doctoral degrees at UC Berkeley, completing his dissertation on natural image ensembles and sensory signal processing — exploring the statistical structure of natural scenes and how the visual system might be optimized to represent them efficiently. After postdoctoral work, he moved into industry and eventually to Genentech, where he serves as director of digital pathology in oncology biomarker development, applying computational and imaging methods to accelerate cancer diagnostics.
EDUCATION
Graduate Studies
University of California, Berkeley
Physics
Graduate Thesis
Natural Ensembles and Sensory Signal Processing
Undergraduate Studies
University of California, Berkeley
IMPACT STORY
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.
READ MORE
GET IN TOUCH WITH Daniel Ruderman
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit,
